HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryusuke Yoshimi Selected Research

Relapsing Polychondritis

1/2022Case Report: Tocilizumab Treatment for VEXAS Syndrome With Relapsing Polychondritis: A Single-Center, 1-Year Longitudinal Observational Study In Japan.
11/2021Tocilizumab in VEXAS relapsing polychondritis: a single-center pilot study in Japan.
1/2021Pathogenic UBA1 variants associated with VEXAS syndrome in Japanese patients with relapsing polychondritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryusuke Yoshimi Research Topics

Disease

10Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2022 - 01/2012
9Inflammation (Inflammations)
01/2022 - 03/2006
5Rheumatoid Arthritis
01/2022 - 05/2012
4Autoimmune Diseases (Autoimmune Disease)
11/2021 - 01/2012
3Arthritis (Polyarthritis)
10/2022 - 11/2021
3Relapsing Polychondritis
01/2022 - 01/2021
2Oral Ulcer (Mouth Ulcer)
10/2022 - 07/2021
2Ulcer
10/2022 - 10/2016
2Infections
08/2022 - 09/2020
2Systemic Scleroderma (Systemic Sclerosis)
03/2022 - 01/2022
2Myocarditis (Carditis)
01/2022 - 01/2021
2Necrosis
01/2022 - 07/2021
2Disease Progression
01/2022 - 02/2003
2VEXAS syndrome
01/2022 - 11/2021
2Rheumatic Diseases (Rheumatism)
01/2022 - 01/2021
2Psychotic Disorders (Schizoaffective Disorder)
01/2022 - 01/2021
2Neoplasms (Cancer)
07/2021 - 01/2021
2Interstitial Lung Diseases (Interstitial Lung Disease)
09/2020 - 01/2016
1Oral Manifestations
10/2022
1Skin Ulcer
10/2022
1Erythema Nodosum
10/2022
1Fibrosis (Cirrhosis)
08/2022
1POEMS Syndrome (Syndrome, POEMS)
08/2022
1Polyneuropathies (Polyneuropathy)
08/2022
1Edema (Dropsy)
08/2022
1Thrombocytopenia (Thrombopenia)
08/2022
1Churg-Strauss Syndrome (Allergic Angiitis)
01/2022
1Eosinophilia
01/2022
1Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
01/2022
1Vasculitis (Vasculitides)
01/2022
1Asthma (Bronchial Asthma)
01/2022
1Paralysis (Palsy)
01/2022
1Bone Fractures (Bone Fracture)
01/2022
1Ischemia
01/2022
1Chronic Kidney Failure (Chronic Renal Failure)
01/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022
1Neurologic Manifestations (Neurological Manifestations)
01/2022
1Familial Mediterranean Fever (Periodic Disease)
12/2021
1Atherosclerosis
11/2021
1Carotid Artery Diseases
11/2021
1Nausea
07/2021
1Hypertension (High Blood Pressure)
06/2021
1Exanthema (Rash)
01/2021
1Myasthenia Gravis
01/2021
1Myositis (Idiopathic Inflammatory Myopathies)
01/2021
1Iridocyclitis
01/2021
1Adult-Onset Still's Disease
01/2021
1Arthralgia (Joint Pain)
01/2021
1Cognitive Dysfunction
01/2021
1Dermatomyositis (Dermatopolymyositis)
09/2020
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
01/2020

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
08/2022 - 01/2012
4Prednisolone (Predate)FDA LinkGeneric
01/2022 - 09/2020
4AntibodiesIBA
11/2021 - 01/2012
3GlucocorticoidsIBA
01/2022 - 01/2021
3AutoantibodiesIBA
11/2021 - 01/2012
3Biomarkers (Surrogate Marker)IBA
11/2021 - 09/2020
3AutoantigensIBA
11/2021 - 01/2012
3IntegrinsIBA
02/2014 - 05/2004
2apremilastIBA
10/2022 - 07/2021
2InterferonsIBA
08/2022 - 11/2018
2tocilizumab (atlizumab)FDA Link
01/2022 - 11/2021
2EnzymesIBA
01/2022 - 01/2021
2Biological ProductsIBA
11/2021 - 11/2019
2CytokinesIBA
11/2021 - 01/2020
2Interferon Type IIBA
11/2021 - 10/2018
2Immunosuppressive Agents (Immunosuppressants)IBA
07/2021 - 01/2021
2Transcription Factors (Transcription Factor)IBA
01/2021 - 02/2014
1C-Reactive ProteinIBA
08/2022
1Reticulin (Reticular Fiber)IBA
08/2022
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022
1mepolizumabIBA
01/2022
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2022
1Rituximab (Mabthera)FDA Link
01/2022
1MethylprednisoloneFDA LinkGeneric
01/2022
1DenosumabFDA Link
01/2022
1Vitamin DFDA LinkGeneric
01/2022
1PyrinIBA
12/2021
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
11/2021
1Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
11/2021
1Abatacept (Orencia)FDA Link
11/2021
1ColchicineFDA LinkGeneric
07/2021
1Pharmaceutical PreparationsIBA
07/2021
1LDL CholesterolIBA
06/2021
1Triglycerides (Triacylglycerol)IBA
06/2021
1anti-dsDNA autoantibodyIBA
01/2021
1HLA-A*26 antigenIBA
01/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
01/2021
1LigandsIBA
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1UbiquitinIBA
01/2021
1InflammasomesIBA
01/2021
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020
1InterleukinsIBA
01/2020

Therapy/Procedure

3Therapeutics
01/2022 - 02/2003
2Hematopoietic Stem Cell Transplantation
03/2022 - 01/2022
1Activities of Daily Living (ADL)
01/2022
1Plasma Exchange
01/2020